Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Suite 320, MSC 7232, Bethesda, Maryland 20892, USA.
J Clin Endocrinol Metab. 2013 Mar;98(3):E497-502. doi: 10.1210/jc.2012-3335. Epub 2013 Feb 13.
Epidemiological studies have observed associations between diabetes and a number of different cancers. Yet the association with cancer overall and the interrelationship of diabetes and obesity with cancer have been unclear. OBJECTIVE, DESIGN, SETTING, AND PARTICIPANTS: We evaluated the association between self-reported diabetes and cancer incidence in the NIH-AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study, a prospective cohort in which 295,276 men and 199,591 women completed a questionnaire in 1995-1996 and were followed up for cancer through 2006.
Hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer incidence, overall and by type, were estimated from multivariate Cox proportional hazards models.
Diabetes was positively associated with total incident cancer in women (1.07, 95% CI 1.02-1.12) but inversely in men (0.96, 95% CI 0.93-0.98). However, diabetes was inversely associated with prostate cancer (HR 0.74, 95% CI 0.70-0.78), which constituted 42% of cancers in men. After excluding prostate cancer, diabetes was also positively associated with cancer in men (HR 1.09, 95% CI 1.04-1.14). By site, diabetes was positively associated with anal, bladder, colon, kidney, liver, pancreatic, rectal, and stomach cancers and in women with endometrial cancer. We also evaluated the joint effect of obesity and diabetes and observed that diabetes conferred additional risk, beyond that of overweight or obesity, for cancer overall, excluding prostate, and for certain sites including the bladder, colon, endometrium, kidney, liver, pancreas, rectum, and stomach.
Our results suggest an etiological role for diabetes in a number of cancers, independent of obesity, and that preventing diabetes may contribute to reduced cancer risk.
流行病学研究已经观察到糖尿病与多种不同癌症之间存在关联。然而,糖尿病与癌症总体之间的关联以及糖尿病与肥胖症之间的相互关系尚不清楚。
目的、设计、环境和参与者:我们评估了美国国立卫生研究院-美国退休人员协会(NIH-AARP)饮食与健康研究中自我报告的糖尿病与癌症发病率之间的关联,这是一项前瞻性队列研究,其中 295276 名男性和 199591 名女性在 1995-1996 年完成了一份问卷,并通过 2006 年的癌症随访。
使用多变量 Cox 比例风险模型估算了癌症发病率的风险比(HR)和 95%置信区间(CI),总体和按类型进行。
糖尿病与女性的总癌症发病率呈正相关(1.07,95%CI 1.02-1.12),但与男性呈负相关(0.96,95%CI 0.93-0.98)。然而,糖尿病与前列腺癌呈负相关(HR 0.74,95%CI 0.70-0.78),占男性癌症的 42%。排除前列腺癌后,糖尿病与男性癌症也呈正相关(HR 1.09,95%CI 1.04-1.14)。按部位,糖尿病与肛门、膀胱、结肠、肾脏、肝脏、胰腺、直肠和胃癌以及女性子宫内膜癌呈正相关。我们还评估了肥胖和糖尿病的联合效应,发现糖尿病除了超重或肥胖外,还会增加癌症总体、前列腺癌以外以及某些部位(包括膀胱、结肠、子宫内膜、肾脏、肝脏、胰腺、直肠和胃)的癌症风险。
我们的结果表明,糖尿病在多种癌症中具有病因学作用,与肥胖无关,预防糖尿病可能有助于降低癌症风险。